Clinical trial
2D and 3D Contrast Enhanced Ultrasound of Chemoembolization
NCT06261814 is registered in ClinicalTrials.gov with john eisenbrey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 2D and 3D Contrast Enhanced Ultrasound of Chemoembolization
- Lead sponsor
- john eisenbrey
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 7, 2024
- Completion date
- January 1, 2028
- Enrollment
- 266 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.